ConductScience.org, home

Paper3315282

Treatment of acute leukemia and malignant lymphoma with (2"R)-4'-O-tetrahydropyranyladriamycin.

Ohno R and 9 others. Cancer Chemother Pharmacol, 1987. Cited by 9 papers, by iCite.

Cite this record

ConductScience Library. Treatment of acute leukemia and malignant lymphoma with (2"R)-4'-O-tetrahydropyranyladriamycin. Papers, record 3315282. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3315282

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Treatment of acute leukemia and malignant lymphoma with (2"R)-4'-O-tetrahydropyranyladriamycin.
PubMed
Journal
Cancer Chemother Pharmacol
PubMed
Year
1987
PubMed
Publication types
Clinical Trial, Comparative Study, Controlled Clinical Trial, Journal Article
PubMed
Citations, by iCite
9
iCite
Relative citation ratio, by iCite
0.63
iCite
Revised in PubMed
2026-10-10
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ohno RR
2Kimura KK
3Amaki II
4Hirano MM
5Hoshino AA
6Ikeda YY
7Kimura II
8Kobayashi MM
9Konno KK
10Majima HH

Source PubMed

Download CSV of authors

Topics19

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
DoxorubicinMajor topic
Leukemia, LymphoidMajor topic
Leukemia, Myeloid, AcuteMajor topic
LymphomaMajor topic
Adult
Aged
Aged, 80 and over
Antibiotics, Antineoplastic
Clinical Trials as Topic
Drug Administration Schedule
Electrocardiography
Female
Heart
Hodgkin Disease
Humans
Lymphoma, Non-Hodgkin
Male
Middle Aged
Naphthacenes

Source PubMed

Download CSV of topics

References24

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
13963850[Phase II study of (2''R)-4'-O-tetrahydropyranyladriamycin (THP) in patients with solid tumors. Multi-Institutional Cooperative Study].Gan To Kagaku Ryoho1986https://conductscience.org/library/papers/3963850PubMed
26526737Cellular uptake and efflux and cytostatic activity of 4'-O-tetrahydropyranyladriamycin in adriamycin-sensitive and resistant tumor cell lines.J Antibiot (Tokyo)1984https://conductscience.org/library/papers/6526737PubMed
36882000[Preliminary phase II clinical study of 4'-O-tetrahydropyranyl doxorubicin (THP-ADM)].Gan To Kagaku Ryoho1983https://conductscience.org/library/papers/6882000PubMed
43947106[Comparative studies on the pharmacokinetics between THP and adriamycin in the same patients].Gan To Kagaku Ryoho1986https://conductscience.org/library/papers/3947106PubMed
57363403The clinical evaluation of analogs--III. Anthracyclines.Cancer Chemother Pharmacol1980https://conductscience.org/library/papers/7363403PubMed
64179349Daunorubicin in the treatment of acute myelocytic leukaemia.Lancet1969https://conductscience.org/library/papers/4179349PubMed
7373923Preliminary results of a phase II trial of aclacinomycin in acute leukaemia and lymphosarcoma. An oncostatic anthracyclin that is rarely cardiotoxic and induces no alopecia.Cancer Chemother Pharmacol1978https://conductscience.org/library/papers/373923PubMed
83966806[Phase I trial of 4'-O-tetrahydropyranyl-doxorubicin (THP)--a multi-institutional cooperative study].Gan To Kagaku Ryoho1985https://conductscience.org/library/papers/3966806PubMed
93861002THP-ADM in the treatment of acute promyelocytic leukemia.Tohoku J Exp Med1985https://conductscience.org/library/papers/3861002PubMed
105243015Rubidomycin in acute leukaemia in adults.Br Med J1968https://conductscience.org/library/papers/5243015PubMed
116833151Rapid uptake by cultured tumor cells and intracellular behavior of 4'-O-tetrahydropyranyladriamycin.J Antibiot (Tokyo)1983https://conductscience.org/library/papers/6833151PubMed
125474180Phase I and preliminary phase II evaluation of adriamycin (NSC 123127).Cancer Res1970https://conductscience.org/library/papers/5474180PubMed
133954376[Pharmacokinetic studies of THP-ADM (tetrahydropyranyl adriamycin)].Gan To Kagaku Ryoho1986https://conductscience.org/library/papers/3954376PubMed
141107570Adriamycin-a review.J Natl Cancer Inst1975https://conductscience.org/library/papers/1107570PubMed
157459811Reporting results of cancer treatment.Cancer1981https://conductscience.org/library/papers/7459811PubMed
164290058Daunomycin, an antitumor antibiotic, in the treatment of neoplastic disease. Clinical evaluation with special reference to childhood leukemia.Cancer1967https://conductscience.org/library/papers/4290058PubMed
17528373Tetrahydropyranyl derivatives of daunomycin and adriamycin.J Antibiot (Tokyo)1979https://conductscience.org/library/papers/528373PubMed
185278102Daunorubicin (NSC 82151) in the treatment of advanced childhood lymphoblastic leukemia.Cancer Res1971https://conductscience.org/library/papers/5278102PubMed
19528374Low heart and skin toxicity of a tetrahydropyranyl derivative of adriamycin (THP-ADM) as observed by electron and light microscopy.J Antibiot (Tokyo)1979https://conductscience.org/library/papers/528374PubMed
203947112[A phase II study of (2''R)-4'-0-tetrahydropyranyladriamycin (THP) in patients with hematological malignancies. THP Study Group].Gan To Kagaku Ryoho1986https://conductscience.org/library/papers/3947112PubMed

See all 24 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.

PMIDTitleJournalYearIn Papers
8725039Radiofrequency capacitive hyperthermia combined with irradiation or chemotherapy for patients with invasive bladder cancers.Int Urol Nephrol1995https://conductscience.org/library/papers/8725039

Source PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3315282

GET https://conductscience.org/api/papers/v1/3315282/references?page=2